InnoCare Pharma Limited (HKG:9969)

Hong Kong · Delayed Price · Currency is HKD

13.65

-0.83 (-5.73%)

Sep 10, 2026, 11:59 AM HKT

InnoCare Pharma Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	2,781	2,375	1,009	738.54	625.4	1,043
Revenue Growth	110.46%	135.27%	36.68%	18.09%	-40.04%	76368.70%
Gross Profit	2,547	2,184	870.9	610.1	482.01	977.37
Operating Income	704.69	452.3	-521.47	-671.67	-777.4	-182.53
Net Income	918.91	642.47	-440.63	-631.26	-886.59	-64.55
Earnings Per Share	0.51	0.38	-0.26	-0.37	-0.60	-0.05
EPS Growth	-	-	-	-	-	-

Revenue by Geography

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
China	1,706	1,439	1,005	673.13	-	-
Foreign	1,074	935.79	4.24	65.4	57.37	826.97
Total	2,781	2,375	1,009	738.54	625.4	1,043

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	7,892	7,072	7,000	8,287	9,011	6,246
Total Debt	2,233	1,611	1,575	1,655	1,540	1,306
Net Cash (Debt)	5,659	5,461	5,425	6,632	7,471	4,940
Net Cash Growth	2.56%	0.66%	-18.20%	-11.22%	51.24%	76.67%
Net Cash Per Share	3.11	3.23	3.20	3.89	5.05	3.62

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	227.19	83.9	-365.55	-665.49	-565.55	167.06
Capital Expenditures	-84.35	-70.16	-78.23	-254.65	-227.24	-169.77
Free Cash Flow	142.84	13.74	-443.78	-920.14	-792.79	-2.71
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	91.61%	91.95%	86.28%	82.61%	77.07%	93.70%
Operating Margin	25.34%	19.05%	-51.66%	-90.95%	-124.30%	-17.50%
Pretax Margin	33.57%	27.61%	-44.84%	-87.23%	-142.90%	-1.93%
Profit Margin	33.05%	27.05%	-43.65%	-85.47%	-141.76%	-6.19%
FCF Margin	5.14%	0.58%	-43.96%	-124.59%	-126.76%	-0.26%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 10, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	24.82	33.13	-	-	-	-
P/FCF Ratio	180.30	1548.92	-	-	-	-
PS Ratio	9.26	8.96	11.38	16.11	33.17	16.48